These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8771187)

  • 1. Engineering linear F(ab')2 fragments for efficient production in Escherichia coli and enhanced antiproliferative activity.
    Zapata G; Ridgway JB; Mordenti J; Osaka G; Wong WL; Bennett GL; Carter P
    Protein Eng; 1995 Oct; 8(10):1057-62. PubMed ID: 8771187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering Fab' fragments for efficient F(ab)2 formation in Escherichia coli and for improved in vivo stability.
    Rodrigues ML; Snedecor B; Chen C; Wong WL; Garg S; Blank GS; Maneval D; Carter P
    J Immunol; 1993 Dec; 151(12):6954-61. PubMed ID: 7903100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering high affinity humanized anti-p185HER2/anti-CD3 bispecific F(ab')2 for efficient lysis of p185HER2 overexpressing tumor cells.
    Zhu Z; Lewis GD; Carter P
    Int J Cancer; 1995 Jul; 62(3):319-24. PubMed ID: 7628874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering a humanized bispecific F(ab')2 fragment for improved binding to T cells.
    Rodrigues ML; Shalaby MR; Werther W; Presta L; Carter P
    Int J Cancer Suppl; 1992; 7():45-50. PubMed ID: 1428403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of domain deletion, glycosylation, and long IgG3 hinge on the biodistribution and serum stability properties of a humanized IgG1 immunoglobulin, hLL2, and its fragments.
    Leung SO; Qu Z; Hansen HJ; Shih LB; Wang J; Losman MJ; Goldenberg DM; Sharkey RM
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3106s-3117s. PubMed ID: 10541351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High level expression of chimeric antibody fragment F(ab')2 directed against CD20 in Escherichia coli].
    Xiong DS; Zheng MJ; Liu YX; Xu YF; Wang JH; Yang CZ
    Sheng Wu Gong Cheng Xue Bao; 2004 Sep; 20(5):673-8. PubMed ID: 15973988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High level Escherichia coli expression and production of a bivalent humanized antibody fragment.
    Carter P; Kelley RF; Rodrigues ML; Snedecor B; Covarrubias M; Velligan MD; Wong WL; Rowland AM; Kotts CE; Carver ME
    Biotechnology (N Y); 1992 Feb; 10(2):163-7. PubMed ID: 1368228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of F(ab')
    Rosenstein S; Vaisman-Mentesh A; Levy L; Kigel A; Dror Y; Wine Y
    Curr Protoc Mol Biol; 2020 Jun; 131(1):e119. PubMed ID: 32319727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
    Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
    MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective antitumor effect of thioether-linked immunotoxins composed of gelonin and monoclonal antibody to alpha-fetoprotein or its F(ab')2 fragment.
    Masuda K; Takahashi K; Hirano K; Takagishi Y
    Tumour Biol; 1994; 15(3):175-83. PubMed ID: 7521059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and tumor-seeking properties of recombinant and nonrecombinant anti-carcinoembryonic antigen antibody fragments.
    Groulet A; Dorvillius M; Pèlegrin A; Barbet J; Baty D
    Int J Cancer; 2002 Jul; 100(3):367-74. PubMed ID: 12115555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable, genetically engineered F(ab')(2) fragments of chimeric TNT-3 expressed in mammalian cells.
    Khawli LA; Biela BH; Hu P; Epstein AL
    Hybrid Hybridomics; 2002 Feb; 21(1):11-8. PubMed ID: 11991812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.
    Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G
    Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
    Molthoff CF; Pinedo HM; Schlüper HM; Nijman HW; Boven E
    Br J Cancer; 1992 May; 65(5):677-83. PubMed ID: 1586596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Method for the preparation of bispecific F(ab')2mu fragments from mouse monoclonal antibodies of the immunoglobulin M class and characterization of the fragments.
    Morimoto K; Inouye K
    J Immunol Methods; 1999 Apr; 224(1-2):43-50. PubMed ID: 10357205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the in vitro and in vivo activities of IgG and F(ab')2 fragments of a mixture of three monoclonal anti-Her-2 antibodies.
    Spiridon CI; Guinn S; Vitetta ES
    Clin Cancer Res; 2004 May; 10(10):3542-51. PubMed ID: 15161714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
    Tahtis K; Lee FT; Smyth FE; Power BE; Renner C; Brechbiel MW; Old LJ; Hudson PJ; Scott AM
    Clin Cancer Res; 2001 Apr; 7(4):1061-72. PubMed ID: 11309358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab' and F(ab')2.
    Better M; Bernhard SL; Lei SP; Fishwild DM; Lane JA; Carroll SF; Horwitz AH
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):457-61. PubMed ID: 7678457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507.
    Heskamp S; van Laarhoven HW; Molkenboer-Kuenen JD; Bouwman WH; van der Graaf WT; Oyen WJ; Boerman OC
    Mol Pharm; 2012 Aug; 9(8):2314-21. PubMed ID: 22747077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low temperature pepsin proteolysis. An effective procedure for mouse IgM F(ab')2 fragment production.
    Pascual DW; Clem LW
    J Immunol Methods; 1992 Feb; 146(2):249-55. PubMed ID: 1538146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.